Bain Capital Life Sciences Investors, LLC Adagio Therapeutics, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $489 Million
- Q2 2024
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 1,799,595 shares of ADGI stock, worth $5.96 Million. This represents 1.22% of its overall portfolio holdings.
Number of Shares
1,799,595
Previous 1,799,595
-0.0%
Holding current value
$5.96 Million
Previous $5.96 Million
-0.0%
% of portfolio
1.22%
Previous 0.9%
Shares
3 transactions
Others Institutions Holding ADGI
# of Institutions
82Shares Held
67.3MCall Options Held
720KPut Options Held
600-
Lee Ainslie Maverick Capital LTD | Dallas, Tx11.8MShares$38.9 Million0.77% of portfolio
-
Deep Track Capital, LP Greenwich, CT11MShares$36.3 Million1.19% of portfolio
-
M28 Capital Management LP Stamford, CT9.25MShares$30.6 Million35.29% of portfolio
-
Black Rock Inc. New York, NY4.47MShares$14.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.3MShares$14.2 Million0.0% of portfolio
About Adagio Therapeutics, Inc.
- Ticker ADGI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 108,831,000
- Market Cap $505M
- Description
- Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...